Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $2.37M 18.3K sh | Aug 7, 2026 |
| 15 | Creviston Steven ESVP, Connectivity & Sensors | Tax withholding | F | $375K 3,949 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Garis Douglas MichaelEVP&CFO | Tax withholding | F | $306K 11.7K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Kelly-Gemmell Dorothy ElizabethDirector | Grant or award | A | — 6,333 sh | Aug 7, 2026 traded Aug 1, 2026 |
| 15 | Fego Paul JSVP, Global Operations | Tax withholding | F | $375K 3,944 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Hopmans JohnEVP, M&A and Strategic Finance | Tax withholding | F | $722K 3,970 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 15 | Hoffman Christina MarieSr. VP & Chief Risk Officer | Option exercise | M | $259K 18.0K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 15 | Viljoen NataschaDirector, President & CEO | Open-market sale · 10b5-1 plan | SELL | $807K 7,764 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Kelly-Gemmell Dorothy ElizabethDirector | Grant or award | A | — 40.8K sh | Aug 7, 2026 traded Aug 1, 2026 |
| 15 | Buonasera DavidCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $22K 871 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 14 | Bruggeworth Robert ADirector, President and CEO | Tax withholding | F | $1.56M 16.4K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Stewart Andrew J.President, GPIC | Grant or award | A | — 16.8K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $49K 7,000 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 13 | Lazar David E.Director, Chief Executive Officer, 10% Owner | Derivative conversion | C | — 124.7K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Gallagher CindyCAO | Option exercise | M | — 9,592 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Gallagher CindyCAO | Option exercise | M | — 9,070 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 13 | Hashad YehiaEVP of R&D and CMO | Grant or award | A | — 21.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Bonnefoy LucPresident, Surgical | Grant or award | A | — 16.8K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $74K 1,200 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Bailey A Robert DEVP & Chief Legal Officer | Grant or award | A | — 33.6K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $154K 2,430 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $202K 3,096 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $21K 3,000 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Munsch FrederickSVP, Controller and CAO | Grant or award | A | — 9,091 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Eldessouky SamEVP and CFO | Grant or award | A | — 50.3K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Gosser TrishaCFO | Option exercise | M | — 10.4K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 13 | Rudyk James DanielDirector | Grant or award | A | — 48.9K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 12 | Olson DustinDirector, Chief Executive Officer | Tax withholding | F | $77K 11.1K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 12 | Stewart Frank P.SVP, Advanced Cellular | Tax withholding | F | $215K 2,262 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 12 | Saunders Brent LDirector, Chairman of the Board and CEO | Tax withholding | F | $71K 4,231 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 12 | Quinton SashaEVP, Pres. CBG | Option exercise | M | $156K 7,549 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 11 | Feierstein Matthew DavidPresident | Open-market sale · 10b5-1 plan | SELL | $51K 5,000 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 11 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $1.13M 8,895 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 11 | Geisser Melinda L.Chief People Services Officer | Option exercise · 10b5-1 plan | M | $21K 15.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 11 | Medway Richard A.General Counsel | Option exercise · 10b5-1 plan | M | $14K 10.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 11 | Medway Richard A.General Counsel | Option exercise · 10b5-1 plan | M | $14K 10.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 10 | Geisser Melinda L.Chief People Services Officer | Option exercise · 10b5-1 plan | M | $71K 50.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 10 | Walsh Mark T.Director, CEO & Director | Option exercise · 10b5-1 plan | M | $71K 50.0K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 10 | Walsh Mark T.Director, CEO & Director | Option exercise · 10b5-1 plan | M | $158K 50.0K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 10 | O'Brien Michael GrahamCFO | Open-market sale · 10b5-1 plan | SELL | $20K 5,000 sh | Aug 7, 2026 traded Aug 6, 2026 |